Essential medicines for universal health coverage

Veronika J Wirtz; Hans V Hogerzeil; Andrew L Gray; Maryam Bigdeli; Cornelis P de Joncheere; Margaret A Ewen; Martha Gyansa-Lutterodt; Sun Jing; Vera L Luiza; Regina M Mbindyo; Helene Möller; Corrina Moucheraud; Bernard Pécoul; Lembit Rägo; Arash Rashidian; Dennis Ross-Degnan; Peter N Stephens; Yot Teerawattananon; Ellen F M 't Hoen; Anita K Wagner; Prashant Yadav; Michael R Reich

doi:10.1016/S0140-6736(16)31599-9

Essential medicines for universal health coverage

Lancet. 2017 Jan 28;389(10067):403-476. doi: 10.1016/S0140-6736(16)31599-9. Epub 2016 Nov 8.

Authors

Veronika J Wirtz¹, Hans V Hogerzeil², Andrew L Gray³, Maryam Bigdeli⁴, Cornelis P de Joncheere⁵, Margaret A Ewen⁶, Martha Gyansa-Lutterodt⁷, Sun Jing⁸, Vera L Luiza⁹, Regina M Mbindyo¹⁰, Helene Möller¹¹, Corrina Moucheraud¹², Bernard Pécoul¹³, Lembit Rägo¹⁴, Arash Rashidian¹⁵, Dennis Ross-Degnan¹⁶, Peter N Stephens¹⁷, Yot Teerawattananon¹⁸, Ellen F M 't Hoen², Anita K Wagner¹⁹, Prashant Yadav²⁰, Michael R Reich²¹

Affiliations

¹ Department of Global Health/Center for Global Health and Development, Boston University School of Public Health, Boston, MA, USA. Electronic address: vwirtz@bu.edu.
² Global Health Unit, Department of Health Sciences, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
³ Division of Pharmacology, Discipline of Pharmaceutical Sciences, University of KwaZulu-Natal, Durban, South Africa.
⁴ World Health Organization, Geneva, Switzerland.
⁵ Department of Essential Medicines and Health Products, Geneva, Switzerland.
⁶ Health Action International, Amsterdam, Netherlands.
⁷ Ministry of Health, Accra, Ghana.
⁸ Peking Union Medical College School of Public Health, Beijing, China.
⁹ National School of Public Health Sergio Arouca, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
¹⁰ World Health Organization, Country Office, Nairobi, Kenya.
¹¹ United Nations Children's Fund, Supply Division, Copenhagen, Denmark.
¹² UCLA Fielding School of Public Health, University of California, Los Angeles, CA, USA.
¹³ Drugs for Neglected Diseases initiative, Geneva, Switzerland.
¹⁴ Regulation of Medicines and other Health Technologies, Geneva, Switzerland.
¹⁵ Department of Information, Evidence and Research, Eastern Mediterranean Region, World Health Organization, Cairo, Egypt; School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
¹⁶ Research, Eastern Mediterranean Region, World Health Organization, Cairo, Egypt; Harvard Medical School, Boston, MA, USA; Harvard Pilgrim Health Care Institute, Boston, MA, USA.
¹⁷ IMS Health, London, UK.
¹⁸ Health Intervention and Technology Assessment Program (HITAP), Thai Ministry of Public Health Nonthaburi, Thailand.
¹⁹ Research, Eastern Mediterranean Region, World Health Organization, Cairo, Egypt; Harvard Medical School, Boston, MA, USA.
²⁰ William Davidson Institute at the University of Michigan, Ann Arbor, MI, USA.
²¹ Harvard T H Chan School of Public Health, Boston, MA, USA.

No abstract available

Publication types

Review

MeSH terms

Conservation of Natural Resources*
Developing Countries*
Drug Costs*
Drugs, Essential / economics*
Drugs, Essential / standards
Drugs, Essential / supply & distribution
Health Expenditures*
Humans
Universal Health Insurance*
World Health Organization

Substances

Drugs, Essential

Publication types

MeSH terms

Substances

Grants and funding